177 related articles for article (PubMed ID: 20090981)
1. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
[TBL] [Abstract][Full Text] [Related]
3. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
[TBL] [Abstract][Full Text] [Related]
7. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
Saxena BB; Zhu L; Hao M; Kisilis E; Katdare M; Oktem O; Bomshteyn A; Rathnam P
Bioorg Med Chem; 2006 Sep; 14(18):6349-58. PubMed ID: 16777417
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners.
Sharma M; Sharma PD; Bansal MP; Singh J
Chem Biodivers; 2007 May; 4(5):932-9. PubMed ID: 17511006
[TBL] [Abstract][Full Text] [Related]
9. A novel synthetic oleanolic acid derivative with amino acid conjugate suppresses tumour growth by inducing cell cycle arrest.
Lu XM; Yi HW; Xu JL; Sun Y; Li JX; Cao SX; Xu Q
J Pharm Pharmacol; 2007 Aug; 59(8):1087-93. PubMed ID: 17725850
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
Ghous Z; Akhter J; Pourgholami MH; Morris DL
Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
[TBL] [Abstract][Full Text] [Related]
13. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure and cytotoxicity of 3-C, N, S, Se substituted benzo[b]selenophene derivatives.
Arsenyan P; Paegle E; Belyakov S; Shestakova I; Jaschenko E; Domracheva I; Popelis J
Eur J Med Chem; 2011 Aug; 46(8):3434-43. PubMed ID: 21621884
[TBL] [Abstract][Full Text] [Related]
15. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
Li JF; Zhao Y; Cai MM; Li XF; Li JX
Eur J Med Chem; 2009 Jul; 44(7):2796-806. PubMed ID: 19171409
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 9,9-dialkyl-4,5-diazafluorene derivatives and their structure-activity relationships toward human carcinoma cell lines.
Wang Q; Yuen MC; Lu GL; Ho CL; Zhou GJ; Keung OM; Lam KH; Gambari R; Tao XM; Wong RS; Tong SW; Chan KW; Lau FY; Cheung F; Cheng GY; Chui CH; Wong WY
ChemMedChem; 2010 Apr; 5(4):559-66. PubMed ID: 20209565
[TBL] [Abstract][Full Text] [Related]
18. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
19. In vivo and In vitro effect of a nutrient mixture on human hepatocarcinoma cell line SK-HEP-1.
Roomi MW; Roomi NW; Kalinovsky T; Niedzwiecki A; Rath M
Exp Oncol; 2010 Jul; 32(2):84-91. PubMed ID: 20693968
[TBL] [Abstract][Full Text] [Related]
20. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
